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Abstract
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Tobacco and marijuana are some of the most common prenatal substance exposures worldwide.
The social acceptability and political landscape of marijuana and its potency have changed
dramatically in the last two decades leading to increased use by pregnant women. Despite
evidence for increasing marijuana use and high rates of co-use of tobacco (TOB) and marijuana
(MJ) during pregnancy, the impact of prenatal exposure to each substance is typically studied in
isolation. We investigated the influence of co-exposure to TOB and MJ on infant neurobehavioral
development over the first postnatal month. Participants were 111 mother-infant pairs from a lowincome, diverse sample (Mean age=25±5; 54% minorities). TOB and MJ use were assessed by
Timeline Followback interview with biochemical confirmation. Three groups were identified: (a)
prenatal MJ+TOB, (b) prenatal TOB only, (c) controls. Newborn neurobehavior was assessed at
seven time points over the first postnatal month using the NICU Network Neurobehavioral Scale.
MJ+TOB-exposed infants showed decreased ability to selfsoothe (Self-regulation) and attend to
stimuli (Attention), and increased need for examiner soothing (Handling) and low motor activity
1Non-standard Abbreviations: TOB - Tobacco - MJ - Marijuana - THC - Δ9-tetrahydrocannabinol - BAM BAM - Behavior and
Mood in Babies and Mothers study - NNNS - NICUNetwork Neurobehavioral Scale - ETS - environmental tobacco smoke - CO carbon monoxide - SES - socioeconomic status r for publication
Correspondence concerning this article should be addressed to Laura R. Stroud, Centers for Behavioral and Preventive Medicine, Coro
West, Suite 309, 164 Summit Avenue, Providence, RI 02906. Electronic mail may be sent to Laura_Stroud@brown.edu.
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(Lethargy) versus unexposed infants. Despite low levels of MJ use in MJ+TOB co-users, coexposure was associated with nearly double the impact on infant self-soothing and need for
examiner soothing versus TOB-exposure alone. Effects of MJ+TOB co-exposure appeared more
pronounced for daughters than for sons. Although results are preliminary, they highlight additional
risk from dual exposure to MJ+TOB vs. TOB exposure alone, particularly for daughters. Results
also highlight the critical importance of investigating prenatal exposures in concert and the need
for intervention efforts to address MJ co-use in pregnant TOB users.

Keywords
pregnancy; marijuana; tobacco; infant; behavior; NNNS
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1.

Introduction

Author Manuscript

Maternal tobacco (TOB) use during pregnancy remains an enormous public health problem
in the US and worldwide. Despite large-scale public education campaigns, approximately
one of every ten infants in the US is born exposed to tobacco (Curtin and Matthews, 2016;
Drake et al., 2018; Tong et al., 2013; U.S. Department of Health and Human Services,
2014). Infants born to less educated, poor, and underserved mothers show disproportionately
higher rates of TOB exposure (up to ~2 in 10 infants born exposed) (Tong et al., 2013). As
documented in the 2014 Surgeon General’s Report, prenatal exposure to cigarette smoking
is considered causally linked to increased risk for infant morbidity and mortality including
low birth weight, preterm birth, and sudden infant death syndrome (U.S. Department of
Health and Human Services, 2014). In older children and adolescents, suggestive
associations were shown between prenatal TOB exposure and altered neurobehavioral
development, including disruptive behaviors/conduct disorder, attention deficits/attention
deficit hyperactivity disorder, and smoking/nicotine dependence (Gaysina et al., 2013;
Huang et al., 2018; Ruisch et al., 2018; Shenassa et al., 2015; U.S. Department of Health
and Human Services, 2014).

Author Manuscript

Maternal marijuana use during pregnancy is also one of the most widespread prenatal drug
insults in the US and the world (Center for Behavioral Health Statistics and Quality,
2015;World Health Organization, 2016). The social acceptability and political landscape of
marijuana (MJ) have changed dramatically in the US in the last decade, accompanied by
expanding legalization, decriminalization, and medicalization (Pew Research Center, 2015).
Paralleling increased societal acceptance of MJ, rates of MJ use by pregnant women
increased by sixty-two percent between 2002 and 2014, with current estimates of between 1
and 2 infants in every 20 born exposed, and increased rates in poor, young, and lesseducated mothers (Brown et al., 2017; Ko et al., 2015; Substance Abuse and Mental Health
Services, 2012; Substance Abuse and Mental Health Services Administration, 2014).
Further, potency of Δ9-tetrahydro-cannabinol (THC), the primary psychoactive ingredient in
MJ, has increased 300% since 1995 (ElSohly et al., 2016; Mehmedic et al., 2010). The
impact of prenatal MJ exposure on offspring development has received less research
attention relative to tobacco. A recent meta-analysis found no effects of prenatal MJ
exposure on preterm birth, but demonstrated a 77% increased risk for low birthweight in MJ-
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exposed infants (Gunn et al., 2016); however, it was not possible to rule out effects on low
birthweight due to other substance exposures. Longer-term studies have revealed some
evidence for associations between prenatal MJ and impairments in attention and inhibitory
control, impulsivity and hyperactivity, and increased risk of MJ use in child, adolescent, and
young adult offspring (Day et al., 2006; Day et al., 2011; Day et al., 1994; Fried, 2002;
Goldschmidt et al., 2012; Smith et al., 2006; Smith et al., 2016).

Author Manuscript

Approximately twenty to thirty percent of pregnant women who use TOB endorse MJ couse
(Chabarria et al., 2016; Coleman-Cowger et al., 2017; Ko et al., 2015). Rates of TOB co-use
among pregnant women who use MJ are even higher—approximately two-thirds to three
fourths of pregnant MJ users endorse TOB co-use (Chabarria et al., 2016; Coleman-Cowger
et al., 2017; El Marroun et al., 2008; Ko et al., 2015). In non-pregnant populations, MJ+TOB
co-use was associated with worse health outcomes, including increased risk of both MJ and
TOB use disorders, poorer MJ and TOB cessation outcomes, increased psychiatric
conditions, and increased respiratory dysfunction (Agrawal et al., 2012; Peters et al., 2012;
Peters et al., 2014; Rabin and George, 2015). In pregnant women, MJ+TOB co-use was
associated with increased maternal (e.g., asthma and pre-eclampsia) and neonatal health
risks (preterm birth, decreased birthweight and head circumference), increased risk for
maternal psychiatric and alcohol use disorders, increases in other drug and poly-tobacco use,
and difficulty with TOB cessation (Chabarria et al., 2016; Coleman-Cowger et al., 2017;
Emery et al., 2016; Gray et al., 2010).

Author Manuscript

The impact of MJ+TOB on fetal development may be mediated by THC/cannabinoids and
nicotine. Nicotine and THC freely cross the placenta and enter fetal circulation (Little and
VanBeveren, 1996; Luck et al., 1985). In preclinical models, both prenatal nicotine and THC
administration result in persistent alterations in neuronal development—nicotine via
nicotinic acetylcholine receptors and disruption of brain cell replication and differentiation
and THC via cannabinoid receptors and disruption of neuronal wiring (England et al.,
2017a; Levin and Slotkin, 1998; Parsons and Hurd, 2015; Richardson et al., 2016). Both
prenatal nicotine and THC also result in widespread disruption of neurotransmitter systems,
including serotonergic, GABAergic, and dopaminergic systems (England et al., 2017a;
Morena et al., 2016). Although to our knowledge, no preclinical models have investigated
joint effects of prenatal nicotine and THC exposure, it is plausible that disruption of
neuronal development via both nicotinic and endocannabinoid pathways may result in
additive or synergistic effects of prenatal TOB+MJ on offspring neurobehavioral
development.

Author Manuscript

Despite plausible neurobiological mechanisms and evidence for increased maternal and
neonatal health risks from prenatal MJ+TOB exposure, few studies examined the impact of
prenatal co-use on infant neurobehavioral development. Eiden et al. found that MJ+TOB
coexposure was associated with less adaptive autonomic regulation at nine months, which
was then associated with diminished emotion regulation at twenty-four months (Eiden et al.,
2018). Schuetze et al. investigated prenatal MJ+TOB co-exposure effects on infant reactivity
and regulation in the context of maternal and fetal mediators (maternal stress, anger, fetal
growth) (Schuetze et al., 2018). No direct effects were found; however, prenatal MJ+TOB
exposure was associated with altered fetal growth, which was then associated with altered
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regulation and negative affect at 9 months. Finally, El Marroun et al. found effects of
prenatal MJ exposure on offspring inattention and aggressive behavior in 18-month old
infants, the majority of whom were also exposed to tobacco (El Marroun et al., 2011).

Author Manuscript

Multiple prior studies investigated effects of prenatal TOB alone on newborn neurobehavior.
In the early newborn period, TOB-exposed infants have shown increased irritability,
excitability, and need for external soothing versus unexposed infants (Godding et al., 2004;
Law et al., 2003; Mansi et al., 2007; Stroud et al., 2009a). In the later newborn period and in
studies investigating neurobehavior across the first postnatal month, TOB-exposed infants
showed decreased ability to self-soothe (self-regulation), increased need for external
soothing (need for handling), decreased attention to stimuli (attention/orientation), and
alterations in motor activity (including increased lethargy and arousal) (Espy et al., 2011;
Stroud et al., 2016; Stroud et al., 2009b; Yolton et al., 2009). A much smaller number of
studies examined links between prenatal MJ and newborn neurobehavior. In a middle-class,
low risk sample, exposure to prenatal MJ was associated with poorer habituation to visual
stimuli, increased arousal, excitability, and irritability, and decreased ability to self-soothe in
the early newborn period (Fried, 1980; Fried and Makin, 1987). These effects were
corroborated by studies designed to investigate other perinatal risk factors (prenatal cocaine
exposure, adolescent pregnancy) (Coles et al., 1992; de Moraes Barros et al., 2006; Lester et
al., 2002), but were not replicated in a high risk MJ-exposed sample (Richardson et al.,
1989) or in a study of MJ exposure in Jamaican infants (Hayes et al., 1988).

Author Manuscript

Author Manuscript

To our knowledge, no studies have explicitly examined the impact of prenatal MJ+TOB
coexposure on newborn neurobehavioral development over the first postnatal month despite
the importance of this period for (1) establishment of parent-infant attachment, (2)
documenting the earliest unfolding developmental pathways leading to long-term child
behavioral outcomes, and (3) investigating the impact of prenatal exposures prior to longterm exposure to second-hand tobacco/MJ smoke. Instead, effects of prenatal exposure to
MJ or TOB on newborn neurodevelopment have typically been studied in isolation. Because
the goal of many neurodevelopmental studies is to determine fetal neurotoxicity of a specific
substance, typical studies include statistical control for co-exposures, but little systematic
investigation of the potential unique or additive/synergistic impact of co-exposures on
offspring outcomes (Lester and Lagasse, 2010).

Sex-specific effects of both prenatal TOB and prenatal MJ on offspring neurobehavior have
been reported in a small number of studies. In older offspring, there is some evidence that
prenatal TOB exposure exerts a more pronounced impact on offspring behavioral
dysregulation and disruptive behavior disorders in sons, whereas the impact of prenatal TOB
exposure on offspring tobacco and other drug use/disorders (including cannabis, cocaine),
was more pronounced in daughters (Brennan et al., 2002; Coles et al., 2012; Fergusson et
al., 1998; Kandel et al., 1994; Stroud et al., 2014b; Weissman et al., 1999). Further, prenatal
MJ exposure led to increased infant inattention and aggression at 18 months in daughters but
not sons (El Marroun et al., 2011). Sex-specific effects of both prenatal THC and prenatal
nicotine exposure were also documented in animal models (Bonnin et al., 1996; Cross et al.,
2017).
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Despite evidence for overlapping alterations in newborn neurobehavior (including
selfregulation, attention and motor activity) from TOB and MJ examined in isolation, to our
knowledge, no studies investigated the impact of MJ+TOB co-use on newborn
neurobehavior.

Author Manuscript

Thus, our first goal was to investigate the impact of prenatal MJ+TOB vs. TOB only versus
no substance exposure on newborn self-regulation, need for external handling, attention, and
lethargy over the first postnatal month. We hypothesized that MJ+TOB-exposed newborns
would show altered ability to self-regulate, worse attention, and increased lethargy versus
unexposed infants; we also explored the hypothesis that co-exposed infants would show
worse neurobehavioral outcomes versus TOB-exposed infants. Given evidence of sexspecific effects of prenatal TOB and MJ in some prior studies of older offspring, our second
goal was to explore the sex-specific impact of prenatal MJ+TOB vs. TOB only vs. no
substance exposure on newborn neurobehavior.

2.
2.1.

Material and Methods
Study Design.

Author Manuscript
Author Manuscript

As shown in Figure 1, the Behavior and Mood in Babies and Mothers (BAM BAM) study
was a prospective study of effects of maternal tobacco use in pregnancy on fetal and infant
neurobehavior (Stroud et al., 2018; Stroud et al., 2014a; Stroud et al., 2016). Pregnant
mothers were recruited from obstetrical offices, health centers, and community postings
primarily during first and second trimester and were enrolled during late second or third
trimester of pregnancy (M=31 weeks gestation, SD=2) between 2006 and 2010. Mothers
completed between 2 and 4 (M=3, SD=1) interview sessions during second and third
trimesters of pregnancy and at delivery (26–42 weeks gestation) depending on the timing of
study enrollment and their availability for multiple assessments. Fifty percent completed 4
interview sessions; 45% completed 3 interviews, and 5% completed 2 interviews.
Specifically, interview sessions took place at 31±2, 35±1, 36±1 weeks gestation and at 1±1
days post-delivery. Mean number of weeks between interview sessions was 3.5 weeks
(SD=1.4). Meconium was collected following delivery to assess biomarkers for nicotine and
other substances. Postnatal follow-up sessions included infant neurobehavioral examinations
(NICU Network Neurobehavioral Scale; NNNS) and saliva samples to determine infant
exposure to nicotine. Day 1 and Day 32 postnatal sessions also included maternal interview
questions. Postnatal follow-up sessions were conducted up to 7 times over the first postnatal
month (Med=7, M=6) at days 0 (M=8 hours), 1, 2, 4, 5, 11, and 32 (SDs=0.1, 0.3, 0.3, 0.6,
0.4, 2.3, and 3.1 days, respectively). All day 0 and 1 NNNS were conducted in the hospital,
56% of day 2—4 NNNS were conducted in the hospital; 99% of day 5—32 NNNS were
conducted at participants’ homes. Postnatal time points were selected to conduct a detailed
examination of rapid neurodevelopment and potential nicotine withdrawal over the first 5
postnatal days, followed by longitudinal assessment over the remainder of the month (days
11 and 32).
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Participants in the current study were a subsample from the BAM BAM Study (above).
Maternal exclusion criteria included age <18 or >40, regular illicit drug use besides MJ
(meconium confirmed), involvement with child protective services, and serious medical
conditions (e.g., pre-eclampsia, severe obesity). Infants were healthy singletons born >36
weeks gestational age (GA) with no congenital anomalies or serious medical conditions. All
procedures were reviewed and approved by local Institutional Review Boards.

Author Manuscript

One hundred forty-eight pregnant women ages 18–40 enrolled in the study. Of these, six
were excluded for regular opiate or cocaine use, two for involvement with child protective
services, five for maternal medical conditions, and six for delivery ≤ 36 weeks gestation. Ten
infants who did not have neurobehavior data were excluded from analyses. Four participants
who were missing maternal-report data regarding MJ use and four participants who used MJ,
but not TOB, were excluded from analyses given our focus on MJ+TOB co-use. The final
analytic sample (n=111) included 24 MJ+TOB users, 45 tobacco-only (TOB) users and 42
biochemically-verified controls. The MJ+TOB group included participants whose maternal
report or biomarkers were positive for TOB and whose maternal report or biomarkers were
positive for MJ. The TOB group included participants whose maternal report or biomarkers
were positive for TOB, and whose maternal report and biomarkers were negative for MJ.
The Control group included participants whose maternal report and biomarkers were
negative for both TOB and MJ. Infant offspring included 51 daughters and 60 sons.
2.3.

Procedures

Author Manuscript

2.3.1. Maternal Interviews.—During each interview, mothers completed the Timeline
Followback (TLFB) interview (Robinson et al., 2014), a calendar/anchor-based assessment
of tobacco, marijuana, and other substance use, adapted to assess use over pregnancy and
three months prior to conception. Mothers also provided saliva samples for cotinine
determination. Demographic characteristics, caffeine consumption, environmental tobacco
smoke (ETS) exposure, health and pregnancy history and depression were also assessed.
Finally, maternal weight and expired breath carbon monoxide were measured during third
trimester. TLFB other substance use, caffeine, ETS, health and pregnancy history,
depression, and weight were utilized to describe the sample and were also tested as potential
confounders (Section 2.4.). Cotinine and carbon monoxide concentrations were utilized to
examine differences between TOB and MJ+TOB groups.

Author Manuscript

2.3.2. Infant Neurobehavior over the First Postnatal Month.—The NICU
Network Neurobehavioral Scale (NNNS) is an infant neurobehavioral assessment designed
to reveal subtle differences in high-risk and substance-exposed infants (Lester et al., 2004;
Tronick and Lester, 2013). The NNNS follows a standard but flexible (based on infant
behavior) administration sequence that starts with pre-examination observation followed by
neurologic and behavioral components (Lester et al., 2004; Tronick and Lester, 2013). The
exam includes exposure to auditory, visual, social and non-social stimuli and lasts
approximately 30 minutes (M=27 min; SD=5 min). NNNS subscales of focus for the present
study include: Self-Regulation, Handling (need for external soothing of the infant to
maintain a quiet alert state), Lethargy, and Attention. All NNNS were administered by
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certified examiners who were blind to maternal substance exposure during pregnancy. Saliva
samples collected at the time of the final NNNS examination (Day 32) were utilized to
determine infant exposure to nicotine via environmental tobacco smoke (ETS) or breast
milk. Time between last feeding and start of NNNS was recorded for use as an a priori
covariate in multivariate models.
2.4.

Bioassays
2.4.1. Saliva cotinine.—Saliva cotinine is a reliable biomarker for nicotine
concentrations (Jarvis et al., 1987). Maternal and infant saliva samples were frozen until
analysis by Salimetrics (www.Salimetrics.com) using highly-sensitive enzyme
immunoassay. Intra and inter-assay coefficients of variation were 6.4% and 6.6%.

Author Manuscript

2.4.2. Breath Carbon Monoxide—Expired alveolar carbon monoxide (CO) is a
biomarker of recent exposure to TOB or MJ combustion (Sandberg et al., 2011). CO
concentrations in expired breath samples were measured in duplicate using the Bedfont
Micro 4 Smokerlyzer (Bedfont® Scientific Ltd).
2.4.3. Meconium nicotine and cannabinoid biomarkers—Meconium was
analyzed for nicotine markers (nicotine, cotinine, trans-3′hydroxycotinine), cannabinoid
markers (Δ9-tetrahydrocannabinol (THC), 11-nor-9-carboxyTHC, cannabinol, 11-hydroxyTHC, di-OH-THC), opiates, cocaine, and amphetamines via EMIT screens, tandem liquid
chromatography mass spectrometry or gas chromatography mass spectroscopy confirmation
(Gray et al., 2009b; Moore et al., 1998). Samples from all participants were negative for
cocaine, opiates, and amphetamines. Samples with nicotine or cannabinoid markers ≥10
ng/g were considered positive for nicotine and/or cannabinoids (Gray et al., 2009a).

Author Manuscript

2.5.

Measurement of Potential Confounders

Author Manuscript

Multiple potential confounders of the association between prenatal TOB and MJ+TOB and
infant outcomes were measured. Maternal demographics: age, race/ethnicity (%
NonHispanic White), Hollingshead socioeconomic status (SES; low SES=Hollingshead ≥
4); and pregnancy history: gravida, parity, were assessed by maternal report. Maternal
gestational medical conditions, e.g., hypertension and diabetes were determined by maternal
report and medical chart review. Weight gain over pregnancy was assessed by maternal
report (prepregnancy) and study measurement (35±1 weeks). Maternal depressive symptoms
were assessed by structured interview using the 21-item Hamilton Depression Rating Scale
(HDRS) (Hamilton, 1960). The HDRS is the most commonly used measure of depression
with demonstrated convergent validity, sensitivity/specificity, and test retest reliability
(Hotopf et al., 1998;Mottram et al., 2000; Rehm and O'Hara, 1985; Reynolds and Kobak,
1995; Williams, 1988). Maternal alcohol use was assessed through TLFB interview
(Robinson et al., 2014). Maternal caffeine use and environmental tobacco smoke (ETS)
exposure were assessed by structured interview; infant ETS exposure was assessed by infant
saliva cotinine. Infant characteristics: sex, delivery mode, GA at birth, small for GA (SGA;
birth weight <10th percentile for GA), and Apgar were assessed by medical chart review.
Feeding method (breast vs. bottle) was assessed by maternal report.
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2.6.1. Testing of potential confounders—Each of the potential confounders
described in Section 2.4 was first tested individually in relation to exposure group (MJ
+TOB, TOB, Control) using Kruskal-Wallis ANOVA as omnibus tests for continuous
confounders, and by Chi-square and Fisher’s exact tests (as appropriate) for discrete
confounders (See Table 1). Potential confounders that showed significant differences across
exposure groups (omnibus ps<.05) were further evaluated for associations with NNNS
outcomes. Those showing significant associations with individual NNNS subscales (ps<.05)
were included in the respective regression models (See below and Table 2). Specifically,
feeding method (any breast-feeding) was a significant confounder for the NNNS SelfRegulation and Handling models; infant ETS and maternal depressive symptom exposure
were significant confounders for the NNNS Lethargy and Attention models. All regression
models also included time since feeding (log-transformed), an important determinant of
infant neurobehavior, as an a priori covariate.

Author Manuscript

2.6.2. Longitudinal regression modeling.—Outcomes exhibiting significant
skewness (NNNS Handling, NNNS Lethargy) were symmetrized via a logarithmic
transformation. Effects of substance-exposure group on infant neurobehavior (NNNS SelfRegulation, Handling, Lethargy, Attention) over the first postnatal month were investigated
using Generalized Least Squares regression modeling (Fitzmaurice et al., 2011). Generalized
least squares regression modeling is an extension of repeated measures analysis of
covariance which allows for: (a) heteroscedastic variances (i.e., unequal variance across
NNNS visits), (b) correlations between NNNS visits for the same participant depending on
their separation in time, (c) incorporation of time-varying covariates (e.g., time since feeding
for each NNNS visit), and (d) intermittent missingness in NNNS visits over time.
Specifically, although 111 infants contributed NNNS exams on at least one visit, NNNS
exams on Days 0, 1, 2, 3, 5, 11, and 32 were missing for 14, 6, 10, 20, 23, 15, and 18 infants
respectively (See Figure 1). Analyses for each outcome of interest were conducted using the
nlme library of R 3.4.2 (https://cran.r-project.org) assuming group-specific variances and a
continuous-time first-order autocorrelation. Residual standard deviations calculated in the
Control group were used to convert group differences into effect sizes.

Author Manuscript

In the present analyses, substance exposure group was the between-subjects factor and infant
age at the NNNS (log-transformed) was the within-subjects factor. Overall differences
between the exposure groups in both outcome levels at the first NNNS exam (intercept) and
with respect to infant age at NNNS exam over the first postnatal month (linear slope) were
tested using multivariate Wald tests with 2 degrees of freedom. Significant omnibus
association tests were followed by examination of pairwise contrasts (MJ+TOB vs. Control,
TOB vs. Control, and MJ+TOB vs. TOB). Both omnibus and pairwise tests were adjusted
for significant confounders. All associations were investigated in an overall model including
all participants, and in identical models stratified by infant sex. Significant confounders from
the overall sample were also utilized for sex-stratified models.
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Descriptive statistics for the overall sample and stratified by substance-exposure group are
presented in Table 1. The sample was primarily low socioeconomic status (55% ≤ high
school education; 57% unemployed; 48% annual income <$20,000), and racially/ethnically
diverse (18% African-American, 25% Hispanic, and 11% Multiracial/Other; 46% NonHispanic White). Infants ranged in age from 0–43 days. There were no significant
differences in average cigarettes per day, or maternal cotinine or CO concentrations between
TOB-only and MJ+TOB users. The 45 TOB-only users reported an average of 10±7, 6±6,
and 5±6 cigarettes per day, and the 24 MJ+TOB users reported an average of 10±8, 6±6, and
4±4 cigarettes per day during first, second, and third trimesters. MJ+TOB users endorsed an
average of 24 days of MJ use (SD=24) over pregnancy, with 24±24, 1±1, and 0.04±0.20
days of use during each trimester. Types of MJ use endorsed included: joints (33%), blunts
(33%), multiple methods (13%; joints + blunts; bowls + joints) and unknown (8%), as well
as three MJ+TOB users (13%) who denied MJ use on the TLFB but had positive meconium
cannabinoids markers.

Author Manuscript

MJ+TOB and TOB-only mothers were more likely to be low SES, to be exposed to ETS,
and showed greater depressive symptoms than Controls; their infants were less likely to be
breast fed and showed increased cotinine vs. Controls. MJ+TOB users were more likely to
use >1 drink/week than Controls; TOB-only users were more likely to use caffeine than
Controls. Of maternal and infant characteristics which differed by exposure group, those that
were also associated with individual NNNS subscales were included as confounders in the
respective regression models below. These included: infant feeding method for NNNS SelfRegulation and Handling, and infant ETS and maternal depressive symptoms for NNNS
Lethargy and Attention.
3.2. Overall impact of MJ+TOB and TOB-exposure on infant neurobehavior over the first
postnatal month.

Author Manuscript

No differences among exposure groups emerged with respect to infant age effects over the
first postnatal month for any NNNS subscale (linear slope x exposure group interaction ps>.
25). Therefore, interest centered upon group differences in outcome levels across NNNS
exams. After control for confounders, associations with exposure groups emerged for all
four NNNS subscales in the overall and sex-stratified samples, except for Attention for
daughters and Lethargy for sons. Associations were negative for Self-Regulation (ps<.001, .
014, .002, respectively) and Attention (ps< .001, .177, .029) and positive for Handling (ps< .
001, .002, .006) and Lethargy (ps<.043, .023, .754).
3.3.

Impact of MJ+TOB and TOB-exposure on NNNS Self-Regulation.
As shown in Table 2 and Figure 2A, both MJ+TOB-exposed and TOB-exposed infants
showed significantly attenuated self-regulation over the first postnatal month vs. unexposed
infants (ps< .03). Using an estimated residual SD of .70 units for the unexposed group, MJ
+TOB-exposed infants showed nearly twice the impact on self-regulation vs. unexposed
infants than was shown for TOB-exposed infants. MJ+TOB-exposed infants showed a .357
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unit decrease (95% CI=.173-.541, p<.001) vs. unexposed infants, and a .185 unit decrease
(95% CI=.007-.363, p=.043) vs. TOB-exposed infants. TOB-exposed infants showed a .172
unit (95% CI=.023-.321, p=.025) decrease vs. unexposed infants.
As shown in Table 2 and Figure 3A, stratifying by infant sex revealed a significant (.318
unit) decrease in self-regulation from TOB-only exposure vs. no exposure for sons (p<.003),
but not daughters (p=.541). Effects of MJ+TOB vs. no exposure were significant for both
sexes (ps<.005), but slightly more pronounced for daughters vs. sons (.426 vs .351 unit
decreases). Finally, daughters (p=.011) but not sons (p=.786) showed a significant difference
(.357 unit decrease) in the impact of MJ+TOB vs. TOB-only exposure on self-regulation.
3.4.

Impact of MJ+TOB and TOB-exposure on NNNS Handling.

Author Manuscript

As shown in Table 2 and Figure 2B, both MJ+TOB-exposed and TOB-exposed infants
showed significantly increased need for external handling over the first postnatal month vs.
unexposed infants. Based on an estimated residual SD of .60 units in the logarithmic scale
for the unexposed group, MJ+TOB-exposed infants showed nearly 2X the impact on
handling vs. unexposed infants than did TOB-exposed infants. MJ+TOB-exposed infants
showed a 32.1% increase in need for handling vs. unexposed infants (95%
CI=16.2%-50.2%, p<.001) and an 12% increase vs. TOB-exposed infants (95% CI=.99–
1.26, p=.066). TOB-exposed infants showed an 18.1% increase vs. unexposed infants (95%
CI=6.0%-31.5%, p=.003).

Author Manuscript

As shown in Table 2 and Figure 3B, stratifying by infant sex revealed a significant (27%)
increase in need for external handling from TOB-only exposure vs. no exposure for sons
(p<.003), but not daughters (p=.178). Effects of MJ+TOB vs. no exposure were significant
for both sexes (ps<.02), but were more pronounced for daughters vs. sons (40% vs. 27%
increases). Finally, daughters (p=.007), but not sons (p=.963) showed a significant difference
(26% increase) in the impact of MJ+TOB vs. TOB-only exposure on need for handling.
3.5.

Impact of MJ+TOB and TOB-exposure on NNNS Attention.

Author Manuscript

As shown in Table 2 and Figure 2C, both MJ+TOB-exposed and TOB-exposed infants
showed significantly decreased attention over the first postnatal month vs. unexposed infants
(ps<.02). Based on an estimated residual SD of 1.41 units for the Control group, MJ
+TOBexposed infants showed a .626 unit decrease in attention (95% CI=.197–1.055, p=.
005) vs. unexposed infants, while TOB-exposed infants showed a .441 unit decrease (95%
CI =.081-.802, p=.017). Although differences between MJ+TOB-exposed vs. TOB-exposed
infants did not attain significance (p=.371) the impact of MJ+TOB was approximately 42%
greater than the impact of TOB alone.
As shown in Table 2 and Figure 3C, stratifying by sex revealed a significant (.585 unit)
decrease in attention from TOB-only exposure vs. no exposure for sons (p=.008), but not
daughters (p=.420). MJ+TOB exposure vs. no exposure led to a trend toward decreased
attention for daughters (.674 unit decrease; p=.063), but not sons (p=.113). Neither
daughters nor sons showed significant differences between MJ+TOB and TOB-only
exposure on attention (ps>.25).
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Impact of MJ+TOB and TOB-exposure on NNNS Lethargy.
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As shown in Table 2 and Figure 2D, MJ+TOB-exposed infants showed a 15% (95% CI =
3%-28%, p=.014) increase in lethargy over the first postnatal month vs. unexposed infants.
TOB-exposed infants showed a trend toward increased lethargy vs. unexposed infants (p=.
098). A residual SD of .39 units in the logarithmic scale was estimated for the unexposed
group. Although no significant differences between MJ+TOB vs. TOB-exposed infants
emerged (p=.256), the impact of MJ+TOB was 75% greater than TOB alone. As shown in
Table 2 and Figure 3D, stratifying by infant sex revealed significant increases in lethargy
from TOB-only exposure (17%) and MJ+TOB exposure (22%) vs. no exposure for
daughters (ps<.05) but no effects of MJ+TOB or TOB-only for sons (ps>.45). No significant
difference between MJ+TOB and TOB-only exposure emerged for daughters or sons for
lethargy (ps>.55).

Author Manuscript

4.

Discussion

Author Manuscript

We found a significant impact of prenatal co-exposure to marijuana and tobacco (MJ+TOB)
on newborn neurobehavior using the NNNS, a neurologic and behavioral examination
sensitive to subtle alterations in behavior in substance-exposed infants (Lester et al., 2004;
Tronick and Lester, 2013). Specifically, MJ+TOB-exposed infants showed lower ability to
self-soothe (NNNS Self-regulation) and attend to stimuli (NNNS Attention), and lower
motor tone and inactivity (NNNS Lethargy), and greater need for external soothing (NNNS
Handling) versus unexposed infants over the first postnatal month. Despite low levels of MJ
co-use and similar TOB use levels between MJ+TOB and TOB groups, MJ+TOB coexposure was associated with nearly double the impact on infant self-soothing and need for
examiner soothing versus TOBexposure alone, and with a 42–75% increased impact on
infant attention and lethargy versus TOB-exposure alone. Finally, we found sex-specific
effects of MJ+TOB; such that effects of coexposure on self-soothing, need for external
soothing, attention, and lethargy were more pronounced for daughters versus sons.

Author Manuscript

NNNS Self-Regulation measures newborns’ capacity to self-soothe, or their ability to
organize motor activity, physiology, and state in response to manipulation and stimulus
presentations during the exam. Conversely, NNNS Handling measures newborns’ need for
external soothing, or their need for intervention from the examiner to soothe the infant and
assist the infant in maintaining a quiet, alert state. MJ+TOB co-exposure resulted in
significant decreases in self-soothing and increases in need for examiner soothing versus no
substance exposure. Moreover, MJ+TOB co-exposure was associated with nearly 200%
increased impact versus TOB exposure alone on self-soothing and need for examiner
soothing. Results complement a recent MJ+TOB co-exposure study which revealed
associations between coexposure and less adaptive autonomic regulation in nine-month old
infants (Eiden et al., 2018). Results also complement prior studies of TOB-exposure alone,
which showed increased irritability, alterations in regulatory processes and increased need
for external soothing across the first postnatal month (Espy et al., 2011; Stroud et al., 2009a;
Stroud et al., 2009b; Yolton et al., 2009). Our findings are also consistent with some prior
prenatal MJ exposure studies that revealed increases in irritability and decreases in selfregulation in the early newborn period (de Moraes Barros et al., 2006; Fried, 1980; Fried and
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Makin, 1987). Our newborn findings are inconsistent with a prior co-exposure study focused
on 9-month-old infants, demonstrating no direct effects of prenatal MJ+TOB on infant
regulation (Schuetze et al., 2018). Thus, it is possible that MJ+TOB effects demonstrated in
the current study are transitory—potentially related to withdrawal processes or neural
development specific to the newborn period—and dissipate by later infancy. Future studies
are needed to replicate current findings and to elucidate the evolution of prenatal coexposure effects over the first postnatal year.

Author Manuscript

Prenatal co-exposure to MJ+TOB also resulted in significant decreases in newborn attention
and increases in lethargy versus no substance exposure. NNNS Attention is a measure of
orientation to animate and inanimate auditory and visual stimuli; NNNS Lethargy is a
measure of infant lethargic behavior or low levels of motor, state, and physiologic reactivity.
Although differences between MJ+TOB versus TOB-only exposure were not statistically
significant for either attention or lethargy, MJ+TOB exposure was associated with a 42%
increased impact on newborn attention and a 75% increased impact on lethargy. Effects on
newborn attention complement prior cross-sectional and longitudinal studies of prenatal
TOB (Espy et al., 2011; Mansi et al., 2007). Although effects of prenatal TOB have been
somewhat inconsistent in early infancy (Law et al., 2003; Stroud et al., 2009b; Yolton et al.,
2009), one of the more consistent long-term effects of prenatal TOB is its association with
child attention deficits, ADHD, and deficits in executive function (Huang et al., 2018;
Micalizzi and Knopik, 2017). In contrast, prior studies of prenatal MJ did not show effects
on attention in the newborn period (de Moraes Barros et al., 2006; Fried, 1980; Fried and
Makin, 1987), although effects on long-term attention and executive function deficits have
been shown (El Marroun et al., 2011; Smith et al., 2006; Smith et al., 2016).

Author Manuscript
Author Manuscript

We can speculate about potential mechanisms underlying effects of MJ+TOB on infant
development. First, it is possible MJ+TOB co-exposure effects are due to increased exposure
to TOB/cigarettes in the MJ+TOB group. However, we found nearly identical average
cigarettes per day in the MJ+TOB versus the TOB-only group (M=7±6 per day for both
groups). Similarly, it is possible that co-exposure effects are due to increased exposure to
nicotine and/or combustion. The majority of MJ+TOB users in our sample endorsed
smoking MJ (e.g., joints, bowls, blunts) versus other methods of use (edibles, vaping)
suggesting increased exposure to combustion. Further, approximately 42% endorsed use of
blunts (partially or fully hollowed cigar wrappers filled with marijuana), which contain
measurable amounts of nicotine and increase in carbon monoxide levels relative to joints
(Cooper and Haney, 2009; Peters et al., 2016). However, we found no differences between
MJ+TOB and TOB groups in 3rd trimester cotinine (nicotine metabolite) or carbon
monoxide levels (marker of exposure to combustion). Nonetheless, because most MJ use
took place during 1st trimester in this sample, it is possible that effects of co-use may be
related to increased nicotine or combustion exposure in early gestation.
Another possibility is that exposure to MJ+TOB (vs. TOB only) may not only disrupt
nicotinic pathways, but also additional pathways in the fetal brain, leading to more profound
alterations in neurodevelopment. THC crosses the placenta and exerts its biological
functions through binding to cannabinoid receptors (Type 1: CB1, and Type 2: CB2) in the
endocannabinoid system, which are present in early fetal development (Bailey et al., 1987;
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Matsuda et al., 1990; Munro et al., 1993; Parsons and Hurd, 2015; Richardson et al., 2016).
The fetal endocannabinoid system regulates several aspects of neural development,
including neurogenesis, neuronal migration, neurite outgrowth and axonal pathfinding
(Vitalis et al., 2008). Preclinical studies have revealed pernicious effects of prenatal THC on
neuronal development via disruption of endocannabinoid signaling pathways (de SalasQuiroga et al., 2015; Szutorisz et al., 2014; Tortoriello et al., 2014). Synergistic effects of
prenatal TOB/nicotine and MJ/THC on glucocorticoid and reward signaling pathways and/or
epigenetic pathways are also plausible (del Arco et al., 2000; Morris et al., 2011; Szutorisz
and Hurd, 2016, 2018).

Author Manuscript

Finally, it is possible that co-exposure effects on offspring outcomes are due to differences in
characteristics of MJ+TOB co-users vs. sole TOB users and controls. Although relevant
demographic characteristics were statistically controlled, it is possible that there were
unmeasured genetic or personality differences that may lead to both maternal MJ+TOB couse and alterations in infant neurobehavior. Future studies with genetically sensitive designs
are needed to tease apart interactions between maternal exposures and maternal
characteristics/ genetics on offspring neurobehavioral outcomes (Bidwell et al., 2016;
D'Onofrio et al., 2014; Fang et al., 2010).

Author Manuscript
Author Manuscript

Our exploratory analyses of sex-specific effects of prenatal MJ+TOB revealed an overall
more pronounced impact of co-exposure on newborn neurobehavior for daughters versus
sons. Specifically, although effects of MJ+TOB on self-regulation and need for external
handling were statistically significant for both sexes, effects were 20% and 50% greater for
daughters than sons, respectively. For attention and lethargy, effects of co-exposure were
significant for daughters only--not sons. Daughter-specific effects of MJ+TOB complement
a study of prenatal MJ and attention and aggression in 18-month olds in which MJ effects
were only significant for daughters, and the majority of MJ-exposed infants were co-exposed
to prenatal TOB (El Marroun et al., 2011). In contrast, we found that effects of prenatal TOB
alone on newborn neurobehavior were specific to sons for most neurobehavioral scales. In
particular, prenatal TOB was associated with decreased self-regulation, increased need for
handling, and decreased attention in sons but not daughters. Son-specific prenatal TOB
effects on newborn behavioral dysregulation are consistent with prior studies highlighting
son-specific prenatal TOB effects on risk for offspring disruptive behavior disorders in older
offspring (Brennan et al., 2002; Fergusson et al., 1998; Weissman et al., 1999). Although
replication of the current pattern of sexspecific findings is needed, we can speculate on
mechanisms. Potential mechanisms may include: (a) sex hormone modulation of effects of
THC+nicotine vs nicotine on fetal neuronal development, (b) sexual differentiation of
emerging fetal brain structures and function may lead to differential impact of THC+nicotine
vs nicotine by fetal sex, (c) sex differences in placental structure and function may modulate
passage of THC+nicotine vs nicotine to the developing fetus, (d) sex differences in genetic
or epigenetic pathways that regulate response to environmental cues, and (e) fetal sexinfluenced differences in the maternal hormonal milieu (Clifton, 2010; Cross et al., 2017;
DiPietro and Voegtline, 2017; Sundram, 2006). Large-scale longitudinal studies powered to
investigate interactions of substance exposures and offspring sex are needed to delineate sexspecific developmental trajectories of coherent, narrow band phenotypes (Wakschlag et al.,
2018) following prenatal co-exposures as well as underlying mechanisms. Comprehensive
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theories are also needed to better integrate relatively inconsistent patterns of findings with
respect to offspring sex within and across exposures, offspring phenotypes, and even species
(e.g., (Sandman et al., 2013).

Author Manuscript

We acknowledge several additional limitations that provide directions for future research.
Key limitations relate to our use of a sample selected to understand maternal tobacco use—
including the small number of MJ+TOB co-users (n=24) and low levels of MJ use. However,
that MJ+TOB co-use effects emerged despite the small co-use sample and low co-use levels
suggests that even larger effects might emerge in a larger sample with greater levels and
more prolonged MJ co-use. Further, although we compared the impact of prenatal MJ+TOB
coexposure to TOB-only exposure, we did not have a MJ-only exposure group. Future
studies need to include both TOB-only and MJ-only groups to determine the unique and
synergistic impacts of MJ and TOB exposures on offspring development. Finally, the present
analyses focused on group differences in the impact of any MJ+TOB and TOB-only
exposure on infant neurobehavior. Future dose-response studies are needed to determine the
quantitative impact of MJ/THC and TOB/nicotine on infant neurobehavior.

Author Manuscript

Findings from the present study highlight the importance of explicitly characterizing the
impact of substance co-exposures on infant outcomes. While single exposure studies (where
effects of other substances are controlled through group inclusion criteria and/or statistical
techniques) are needed to determine specific effects of any given substance, studies designed
to investigate co-exposures also offer potential to inform obstetric providers and pregnant
mothers regarding offspring outcomes following “real-world” co-use behaviors. Future
studies are also needed to explicitly characterize potential additive or multiplicative effects
of additional substance exposures and non-substance exposures including environmental
toxins, poverty, stress, and mental health problems (Clark et al., 2016; Stroud et al., 2014b).

Author Manuscript

Our findings also have implications for intervention and prevention efforts. The first month
is an important period for development of mother-infant attachment. The combination of a
lethargic infant requiring additional external soothing and a co-using mother with fewer
resources and parenting skills could disrupt maternal-infant interactions during this critical
period. Alterations in newborn behavior may themselves portend adverse long-term
outcomes; however, more likely is that subtle differences in newborn behavior in the context
of a less resourced parent may lead to a maladaptive cycle of continued behavioral
dysregulation, further disruptions in maternal-infant attachment, and eventually, long-term
adverse offspring outcomes (Beeghly et al., 2016; Beeghly and Tronick, 1994; Blackwell et
al., 1998; Lester et al., 2009).Results highlight the need for early identification, intervention
and education efforts for parents of exposed/co-exposed infants to prevent disruptions in
early mother-infant attachment and to assist in facilitating self-regulatory skill development.
Results also highlight the need to assess MJ co-use in pregnant TOB users and to educate
pregnant TOB-users regarding potential risks of MJ co-use. The adverse effects of prenatal
TOB have received a great deal of public health attention (England et al., 2017b; Haviland et
al., 2004; Orleans et al., 2004); however, despite increasing availability and use of MJ, both
pregnant women and obstetric providers report a dearth of available information regarding
effects of prenatal MJ use on mothers and offspring (Holland et al., 2016a; Holland et al.,
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2016b; Jarlenski et al., 2016). Novel interventions are also needed to address both TOB use
and MJ co-use.
4.1.

Conclusions
Our findings suggest that the profile of a MJ+TOB co-exposed infant in the newborn period
includes greater difficulty in self-soothing, greater need for external soothing, poorer
attention to stimuli, and greater lethargy. Alterations in newborns’ ability to self-soothe and
need for external soothing were nearly 2X greater for MJ+TOB exposure versus TOB
exposure alone. Results highlight additional risks of dual exposure to MJ+TOB versus TOB
exposure alone and the importance of explicitly characterizing prenatal substance exposures
in concert and in context. Results also highlight the need for intervention efforts to address
MJ co-use in pregnant TOB users and for early identification of co-exposed infants.

Author Manuscript
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HIGHLIGHTS
•

Investigated the impact of marijuana and tobacco co-use in pregnancy on
newborn behavior.

•

Newborns exposed to both marijuana and tobacco showed decreased ability to
self-soothe and attend to stimuli.

•

Co-exposed newborns also needed more external soothing and were more
lethargic.

•

Effects of co-exposure were worse for daughters than for sons.

•

Intervention efforts to address marijuana co-use in pregnant tobacco users are
needed.
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Figure 1.

Overview of the Behavior and Mood in Babies and Mothers (BAM BAM) study. Note:
CO=Breath Carbon Monoxide assessment; NNNS=NICU Network Neurobehavioral Scale.
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Figure 2.

Infant Neurobehavior over the first Postnatal Month in MJ+TOB-exposed, TOBexposed, and
unexposed infants: (a) NICU Network Neurobehavioral Scale (NNNS) SelfRegulation, (b)
NNNS Handling, (c) NNNS Attention, (d) NNNS Lethargy. The NICU Network
Neurobehavioral Scale (NNNS) was administered up to 7 times over the first postnatal
month at days 0 (M=8 hours), 1, 2, 4, 5, 11, and 32. NNNS Lethargy and NNNS Handling
were modeled in the logarithmic scale.
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Infant Neurobehavior over the first Postnatal Month in MJ+TOB-exposed, TOBexposed, and
unexposed daughters and sons: (a) NICU Network Neurobehavioral Scale (NNNS) SelfRegulation, (b) NNNS Handling, (c) NNNS Attention, (d) NNNS Lethargy.
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Maternal and infant characteristics by tobacco (TOB) and marijuana (MJ) exposure group and full sample.
Controls (n=42)
Mean (SD)/ %

TOB (n=45) Mean
(SD)/ %

MJ+TOB (n=24)
Mean (SD)/ %

Total (n=11) Mean
(SD)/ %

Maternal Characteristics
Age (years)

25 (6)

24 (4)

25 (4)

25 (5)

Race/Ethnicity (% Non-Hispanic White)

42%

53%

42%

46%

20%

47%

65%

40%***

Gravida

2.3 (1.6)

2.9 (2.2)

2.6 (1.4)

2.6 (1.8)

Parity

1.0 (1.2)

1.2 (1.5)

1.1 (1.4)

1.1 (1.4)

33 (17)

27 (18)

32 (13)

31 (17)

0%

4%

17%

5%*

5%

39%

21%

22%***

2%

59%

29%

40%***

7%

22%

17%

15%

2 (3)

5 (5)

6 (6)

4 (5)**

0 (0)

7.3 (6.2)

6.8 (5.4)

---

7

0 (0)

96 (111)

75 (91)

---

7

1 (1)

6 (5)

4 (3)

---

Sex (% female)

40%

51%

46%

46%

Delivery Mode (% vaginal delivery)

76%

78%

79%

77%

Gestational age at birth (weeks)

40 (1)

40 (1)

40 (1)

40 (1)

2%

7%

4%

5%

Apgar score (> 8 at 5 minutes)

90%

98%

96%

95%

Any breastfeeding

81%

56%

46%

62%

1 (2)

12 (21)

11 (23)

8 (18)

1

Low SES

2

Weight gain (pounds)

Alcohol Use (>1 drink/week)

Author Manuscript

Caffeine Use (>200 mg/day caffeine)

3

4

High ETS Exposure (>1 hour/day)
Gestational Medical Conditions
Depressive Symptoms

5

6
7

Tobacco Use (cigs/day)

Maternal Cotinine per day (ng/mL)
Maternal Carbon Monoxide (ppm)
Infant Characteristics

Author Manuscript

8

Small for gestational age

ETS Exposure: saliva cotinine (ng/ml)

9

*

NOTE:p<.05;

**

p<.01,

***
p<.001.
1

Based on a score of 4 or 5 on the Hollingshead Index.

2

Author Manuscript

Weight gain in pounds between pre-pregnancy and 35±1 weeks.

3

Equivalent of two cups of coffee per day.

4

Hours of environmental tobacco smoke exposure per week measured by structured interview.

5

e.g., gestational hypertension, gestational diabetes.

6

Score on 21-item Hamilton Depression Rating Scale.
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7

No significant differences between tobacco-only and marijuana+tobacco groups

8

Birthweight <10th percentile for gestational age.

9

Author Manuscript

Environmental Tobacco Smoke exposure measured by infant saliva cotinine at postnatal day 32 (ng/ml).

Author Manuscript
Author Manuscript
Author Manuscript
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Table 2.

Author Manuscript

Impact of marijuana+tobacco (MJ+TOB) co-use and sole tobacco (TOB) use on newborn neurobehavior over
the first postnatal month for the full sample (n=111) and for daughters (n=51) and sons (n=60).
Predictor Variables

Full Sample

Daughters

Sons

β

SE

p

β

SE

p

β

SE

p

5.334

.219

<.001

5.144

.297

<.001

5.543

.317

<.001

.092

.023

<.001

.090

.033

.007

.098

.032

.002

−.020

.035

.569

.040

.046

.387

−.074

.051

.147

Any Breastfeeding

−.193

.073

.008

−.203

.107

.058

−.232

.099

.020

Tobacco

−.172

.076

.025

−.069

.112

.541

−.318

.106

.003

Marijuana + Tobacco

−.357

.094

<.001

−.426

.151

.005

−.351

.119

.003

−.185

.091

.043

−.357

.140

.011

−.033

.122

.786

.983

.180

<.001

.960

.244

<.001

.956

.264

<.001

−.065

.018

<.001

−.075

.025

.003

−.053

.026

.039

.053

.030

.079

.062

.042

.141

.044

.043

.313

Any Breastfeeding

.140

.050

.005

.177

.071

.013

.151

.072

.038

Tobacco

.166

.055

.003

.103

.076

.178

.242

.080

.003

Marijuana + Tobacco

.278

.066

<.001

.334

.092

<.001

.237

.094

.012

MJ+TOB vs. TOB

.112

.061

.066

.231

.086

.007

−.004

.087

.963

3.455

.439

<.001

2.272

.565

<.001

4.390

.612

<.001

.337

.052

<.001

.400

.072

<.001

.296

.068

<.001

.156

.068

.023

.339

.082

<.001

.002

.099

.983

−.010

.004

.023

−.006

.008

.491

−.018

.005

.001

−.058

.016

<.001

−.041

.029

.153

−.076

.021

<.001

Tobacco

−.441

.184

.017

−.257

.318

.420

−.585

.219

.008

Marijuana + Tobacco

−.626

.219

.005

−.674

.361

.063

−.465

.292

.113

MJ+TOB vs. TOBDifference

−.185

.207

.371

−.417

.368

.259

−.119

.261

.649

4,5

2.447

.119

<.001

2.426

.175

<.001

2.418

.161

<.001

6

−.132

.013

<.001

−.134

.019

<.001

−.128

.018

<.001

−.055

.020

.006

−.054

.030

.078

−.052

.027

.054

.002

.001

.031

−.001

.002

.700

.005

.001

.001

.013

.004

.002

.008

.006

.197

.019

.006

.001

.077

.047

.098

.158

.070

.025

.027

.062

.664

1

Self-Regulation

Intercept
Infant age

6

Time since feeding

7

Author Manuscript

MJ+TOB vs. TOB
Difference
2,5

Handling

Intercept
Infant age

6

Time since feeding

7

3

Attention

Author Manuscript

Intercept
Infant age

6

Time since feeding

7

8

Infant ETS

9

Depression Score

Lethargy

Infant age

Intercept

Author Manuscript

Time since feeding

8

Infant ETS

9

Depression Score
Tobacco

7
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Marijuana + Tobacco

.136

.055

.014

.201

.079

.011

.059

.079

.455

MJ+TOB vs. TOBDifference

.058

.051

.256

.044

.074

.553

.032

.072

.656

Author Manuscript

Note:Reference group is unexposed infants for the overall model. Red, italicized coefficients show differences between MJ+TOB versus TOBexposed infants.

1

NICU Network Neurobehavioral Scale (NNNS) Self-Regulation measures the infant’s capacity to organize motor activity, physiology, and state in
response to manipulation and stimulus presentations throughout the exam;

2

NNNS Handling is a measure of need for intervention from the NNNS examiner to soothe the infant and assist the infant in maintaining a quiet,
alert state.

3

NNNS Attention is a measure of orientation to animate and inanimate auditory and visual stimuli.

4

NNNS Lethargy is a measure of low levels of motor, state and physiologic reactivity.

5

NNNS Lethargy and NNNS Handling were natural log transformed.

6

Infant age (measured in hours).

Author Manuscript

7

Time since feeding (measured in mins).

8

Infant Environmental Tobacco Smoke (ETS) exposure measured by saliva cotinine (ng/ml).

9

Maternal depressive symptoms on 21-item Hamilton Depression Rating Scale.

Author Manuscript
Author Manuscript
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